Birch Hill Investment Advisors LLC decreased its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 13.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 50,884 shares of the company's stock after selling 7,950 shares during the period. Birch Hill Investment Advisors LLC's holdings in Procter & Gamble were worth $8,107,000 at the end of the most recent quarter.
A number of other hedge funds also recently bought and sold shares of the business. Kingstone Capital Partners Texas LLC increased its holdings in shares of Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock worth $11,832,680,000 after buying an additional 76,017,350 shares during the last quarter. Nuveen LLC acquired a new stake in shares of Procter & Gamble during the 1st quarter worth approximately $1,954,941,000. Price T Rowe Associates Inc. MD increased its holdings in shares of Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after buying an additional 2,466,308 shares during the last quarter. Invesco Ltd. increased its holdings in shares of Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after buying an additional 2,228,151 shares during the last quarter. Finally, Valeo Financial Advisors LLC increased its holdings in shares of Procter & Gamble by 1,875.5% during the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company's stock worth $280,946,000 after buying an additional 1,674,139 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.
Procter & Gamble Stock Performance
Shares of PG stock opened at $151.61 on Wednesday. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 52 week low of $146.96 and a 52 week high of $180.43. The stock has a market capitalization of $354.84 billion, a PE ratio of 23.29, a P/E/G ratio of 4.03 and a beta of 0.36. The firm has a 50 day moving average of $154.79 and a two-hundred day moving average of $158.54.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.06. The business had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company's revenue for the quarter was up 1.7% on a year-over-year basis. During the same period in the previous year, the company earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, research analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be given a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. The ex-dividend date of this dividend is Friday, October 24th. Procter & Gamble's payout ratio is 64.98%.
Analysts Set New Price Targets
A number of analysts have recently issued reports on PG shares. Evercore ISI restated an "in-line" rating and set a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Barclays cut their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating for the company in a report on Wednesday, October 1st. UBS Group cut their price target on shares of Procter & Gamble from $180.00 to $176.00 and set a "buy" rating for the company in a report on Wednesday, October 8th. Bank of America cut their price target on shares of Procter & Gamble from $180.00 to $174.00 and set a "buy" rating for the company in a report on Wednesday, October 8th. Finally, Berenberg Bank increased their price objective on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a "hold" rating in a research report on Wednesday, September 17th. Eleven analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $171.68.
Check Out Our Latest Research Report on Procter & Gamble
Insider Activity
In related news, CEO Jennifer L. Davis sold 3,227 shares of Procter & Gamble stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $491,246.21. Following the sale, the chief executive officer directly owned 61,764 shares in the company, valued at $9,402,333.72. This trade represents a 4.97% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Shailesh Jejurikar sold 3,986 shares of Procter & Gamble stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $606,788.78. Following the sale, the chief operating officer owned 46,899 shares in the company, valued at $7,139,434.77. This represents a 7.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 149,763 shares of company stock worth $23,421,279 over the last three months. Company insiders own 0.20% of the company's stock.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report